文献速递呼吸危重症与机械通气

高氧对肺炎症及器官损伤的影响:人体在体随机对照试验

Effects of hyperoxia on pulmonary inflammation and organ injury in a human in vivo model (HIPI): a randomised controlled trial.
PubMed 文献 · Thorax · 2026-09-10

该随机双盲安慰剂对照试验在健康成人吸入脂多糖后,比较高流量鼻氧高氧(FiO2 1.0,60 L/min)与合成医用空气各6小时对肺及全身炎症的影响。主要结局支气管肺泡灌洗液IL-8在6小时两组无差异;高氧组BAL还原型谷胱甘肽约升高四倍,24小时出现175个差异表达基因。

要点

  • 吸入LPS后6小时高氧未升高BAL IL-8及全身炎症标志物。
  • 高氧组BAL还原型谷胱甘肽约升高四倍,提示氧化还原反应改变。
  • 24小时全血转录组出现175个差异表达基因,涉及基质重塑与内皮修复。

核心结论

  • 在人体吸入LPS攻击模型中,6小时高氧未增加肺或全身炎症标志物。

研究设计与样本

  • 随机、双盲、安慰剂对照试验;健康成年志愿者按1:1随机接受经高流量鼻氧的高氧(FiO2 1.0,60 L/min)或合成医用空气6小时。

主要发现

  • 6小时BAL IL-8两组无差异:高氧组375.7 pg/mL(IQR 351.1-467.7)vs 安慰剂组331.9 pg/mL(IQR 251.6-459),p=0.33。
  • BAL细胞因子及全身炎症标志物未见组间差异。
  • 高氧与BAL还原型谷胱甘肽约升高四倍相关(未校正p=0.02)。
  • 24小时高氧与独特转录反应相关,175个差异表达基因(padj<0.05),包括细胞外基质重塑、血小板活化及内皮修复相关基因上调。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: It is uncertain whether hyperoxia contributes to adverse intensive care unit outcomes. Potential harm is likely mediated by oxidative stress driving pulmonary and systemic inflammation. METHODS: We conducted a randomised, double-blind, placebo-controlled trial to test the hypothesis that hyperoxia modifies pulmonary and systemic inflammation following inhaled lipopolysaccharide (LPS) challenge. Healthy adult volunteers were randomised (1:1) to receive hyperoxia administered via high-flow nasal oxygen (FiO2 1.0, 60 L/min) or synthetic medical air for 6 hours. Bronchoalveolar lavage (BAL) was performed at 6 hours following inhalation of 50 µg of LPS. Blood was collected at baseline, 6 hours and 24 hours. The primary outcome was BAL interleukin-8 (IL-8). Secondary outcome measures included markers of pulmonary and systemic inflammation. Untargeted metabolomic and lipidomic profiling of BAL fluid and plasma was performed by liquid chromatography-mass spectrometry to investigate oxidative stress. Transcriptomic analysis was also performed on whole blood. RESULTS: Between January 2023 and March 2024, twenty-two participants were recruited and completed all study procedures. BAL IL-8 did not differ between groups at 6 hours (hyperoxia 375.7 pg/mL (IQR 351.1-467.7) vs placebo 331.9 pg/mL (IQR 251.6-459), p=0.33). No between-group differences were observed in BAL cytokines or markers of systemic inflammation. Hyperoxia was associated with an approximately fourfold increase in BAL reduced glutathione (unadjusted p=0.02). Hyperoxia was associated with distinct transcriptional responses at 24 hours with 175 differentially expressed genes (padj <0.05), including upregulation of genes related to extracellular matrix remodelling, platelet activation and endothelial repair. DISCUSSION: In a human inhaled LPS challenge model, 6 hours of hyperoxia did not increase markers of pulmonary or systemic inflammation. TRIAL REGISTRATION NUMBER: NCT05414370.

来源:Thorax,查看原文。版权归原作者所有。

引用

  1. Linden D, Dorrian D, Glenn M, et al. Effects of hyperoxia on pulmonary inflammation and organ injury in a human in vivo model (HIPI): a randomised controlled trial. Thorax. 2026. PMID: 42722424. doi:10.1136/thorax-2026-225321

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。